Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections (CROI) Boston, Massachusetts March 4-7, 2018 Back

Resistance Analyses of Bictegravir/Emtricitabine/Tenofovir Alafenamide Switch Studies       Reported by Jules Levin CROI 2018 March 4-7 Boston MA   Kristen Andreatta, Madeleine Willkom, Ross Martin, Silvia Chang, Hal Martin, Hiba Graham, Erin Quirk, and Kirsten L. White Gilead Sciences, Inc., Foster City, CA